Sagimet Biosciences Inc. Shares Outstanding
Sagimet Biosciences Inc. (SGMT) had Shares Outstanding of 0 shares as of 2023-12-31, per its 10-K filed 2024-03-25.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2024-03-25
- 2023-12-31: Shares outstanding (split-adjusted) 0.00 shares; Shares authorized (split-adjusted) 0.00 shares.
- 2023-09-30: Shares outstanding (split-adjusted) 0.00 shares; Shares authorized (split-adjusted) 0.00 shares.
- 2023-06-30: Shares outstanding (split-adjusted) 210.31K shares; Shares authorized (split-adjusted) 1.64B shares.
- 2023-03-27: Shares outstanding (split-adjusted) (m); Shares authorized (split-adjusted) 1.61B shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-25 | 0.00 shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-13 | 0.00 shares 10-Q · filed 2023-11-13 |
| 2023-06-30 | 210.31K shares 10-Q · filed 2023-08-21 | 1.64B shares 10-Q · filed 2023-08-21 |
| 2023-03-27 | (m) | 1.61B shares 10-Q · filed 2023-08-21 |
| 2022-12-31 | 185.08K shares 10-K · filed 2024-03-25 | 1.61B shares 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |